Search hospitals > Connecticut > New Haven
Yale University
Claim this profileNew Haven, Connecticut 06510
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Recurrence
Conducts research for Leukemia
Conducts research for Breast Cancer
1112 reported clinical trials
190 medical researchers
Summary
Yale University is a medical facility located in New Haven, Connecticut. This center is recognized for care of Cancer, Tumors, Recurrence, Leukemia, Breast Cancer and other specialties. Yale University is involved with conducting 1,112 clinical trials across 1,495 conditions. There are 190 research doctors associated with this hospital, such as Nina S. Kadan-Lottick, Farzana Pashankar, Patricia M Lorusso, and Alessandro Santin.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Tumors
Global LeaderStage IV
Stage III
Stage I
Top PIs
Nina S. Kadan-LottickMedStar Georgetown University Hospital6 years of reported clinical research
Expert in Tumors
Expert in Cancer
37 reported clinical trials
83 drugs studied
Farzana PashankarYale University6 years of reported clinical research
Expert in Tumors
Expert in Neuroblastoma
31 reported clinical trials
73 drugs studied
Patricia M LorussoYale Cancer Center3 years of reported clinical research
Studies Tumors
Studies Solid Tumors
20 reported clinical trials
36 drugs studied
Alessandro SantinSmilow Cancer Hospital at Yale New Haven4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
15 reported clinical trials
24 drugs studied
Clinical Trials running at Yale University
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Multiple Myeloma
Urothelial Carcinoma
Ovarian Tumors
Leukemia
Acute Lymphoblastic Leukemia
Bladder Cancer
ARV-471
for Breast Cancer
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.
Recruiting2 awards Phase 35 criteria
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Yale University?
Yale University is a medical facility located in New Haven, Connecticut. This center is recognized for care of Cancer, Tumors, Recurrence, Leukemia, Breast Cancer and other specialties. Yale University is involved with conducting 1,112 clinical trials across 1,495 conditions. There are 190 research doctors associated with this hospital, such as Nina S. Kadan-Lottick, Farzana Pashankar, Patricia M Lorusso, and Alessandro Santin.
Where is Yale University located?
To reach Yale New Haven Hospital, take Exit 57 to Route 34 east into New Haven, turn right onto Ella T. Grasso Boulevard (Rte. 10), and then left onto South Frontage Road, following the hospital signs. For GPS or online mapping, use 35 Park Street, New Haven, CT 06519.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Yale University hospitals, contact the Billing and Finance Department at 866-341-0673 or visit their website for assistance with bills, coordination of benefits, and premium payments. For specific programs and eligibility, visit the YNHHS Financial Assistance Programs and Eligibility Guidelines page. For billing inquiries or insurance-related questions, call 855-547-4584 or visit the Billing FAQs or Contact Us pages.
What insurance does Yale University accept?
Yale University and its affiliated hospitals, including Yale New Haven Health System, accept a wide range of insurance plans. Coverage varies for individuals at the university, such as students, faculty, and staff. Yale Medicine and Yale New Haven Health System hospitals participate with numerous insurance carriers, including but not limited to Aetna, Anthem, Cigna, ConnectiCare, Medicaid, Medicare, UnitedHealthcare, and TRICARE. It is crucial to confirm with your insurance provider that your desired doctor or healthcare provider is within your network, as exceptions may exist.
What awards or recognition has Yale University received?
Yale New Haven Hospital, in collaboration with Yale University and University College London, focuses on advancing biomedical research and healthcare worldwide. It ranks among the top U.S. hospitals, with national rankings in 11 of 16 specialties such as diabetes and endocrinology, psychiatry, gastroenterology and GI surgery, and gynecology. The hospital is also lauded for its dedication to teaching and clinical research, earning the Joint Commission's Gold Seal of Approval for Advanced Certification for Total Hip and Knee Replacement.